HCPCS C9600: Drug-eluting stent with angioplasty, single vessel

HCPCS C9600: Drug-eluting stent with angioplasty, single vessel

Learn how to bill HCPCS C9600 for a drug-eluting stent with angioplasty in a single coronary artery, including documentation, billing rules, and modifiers.

Use Code
## **What is HCPCS code C9600?** HCPCS code C9600 describes the percutaneous transcatheter placement of drug-eluting intracoronary stent(s) with coronary angioplasty, when performed, in a single major coronary artery or branch. This procedure is a minimally invasive cardiac intervention performed in a hospital outpatient setting or an ambulatory surgery center (ASC) under the CMS Outpatient Prospective Payment System (OPPS) rules. It is used when a drug-eluting stent (DES) is placed to reopen narrowed or blocked coronary arteries caused by atherosclerotic cardiovascular disease, including cases of chronic total occlusion. The angioplasty, often performed with percutaneous transluminal coronary angioplasty (PTCA) and balloon dilation, may be included if carried out during the same intervention. If an additional coronary artery requires treatment in the same session, other add-on C-codes (C9601–C9608) are reported. In some cases, a diagnostic coronary angiography is performed before PCI to confirm disease severity and guide the placement of stents. Unlike non-drug-eluting stents (reported separately), C9600 explicitly covers the use of drug-eluting devices.
## **HCPCS code C9600 documentation requirements** Because C9600 is a device-intensive PCI code maintained by CMS, documentation must clearly demonstrate medical necessity, compliance with coverage rules, and proper reporting under OPPS. ### **Clinical need and medical necessity** The record must establish a covered indication, such as acute myocardial infarction, unstable angina, symptomatic coronary artery disease with significant stenosis, or restenosis after prior percutaneous coronary intervention (PCI). Documentation should note the severity of stenosis (generally ≥70%, or ≥50% in the left main coronary artery) and symptoms or objective evidence of ischemia, consistent with LCD guidance. ### **Procedural details** The operative or cath lab report must describe the target vessel, balloon angioplasty performed, stent deployment technique, and number of stents placed. If more than one vessel was treated, each must be clearly identified. ### **Device description** Include details of the drug-eluting stent(s) used—manufacturer, model, size, and lot number. Affix device stickers to the chart for audit purposes. ### **Orders and compliance** Maintain a signed physician order for PCI, informed consent, and evidence of guideline-directed medical therapy when applicable. For Medicare patients, documentation should also reflect that the intervention aligns with LCD indications and limitations. ### **Pricing support** Attach the vendor invoice or device log, since C9600 is a device-intensive code and reimbursement depends on accurate cost capture.
## **HCPCS C9600 billing requirements** Billing for C9600 must follow CMS rules for PCI with drug-eluting stent placement under the Outpatient Prospective Payment System. ### **Single vessel reporting** Report one unit of C9600 per major coronary artery or branch treated with a drug-eluting stent. If multiple stents are placed in the same vessel, only one unit is reported. If another vessel is treated during the same session, use the appropriate add-on C-codes. ### **Covered indications** Payment requires documentation that the PCI meets LCD criteria, including significant stenosis with symptoms or objective ischemia, acute coronary syndromes, or restenosis after prior PCI. Procedures for non-covered indications (e.g., mild stenosis without ischemia) will be denied. ### **Units and dates** Bill one unit per vessel on the date of the PCI. The service date must match the procedure documented in the cath lab report. ### **Frequency and staging rules** When PCI is staged (e.g., second procedure within 90 days), ensure the claim reflects medical necessity and meets criteria outlined in the LCD. Submit supporting notes if the intervention was staged for clinical reasons, such as complex disease or patient stability. ### **Prior authorization and payer rules** Medicare does not require prior authorization for C9600, but many Medicare Advantage and commercial payers do. Always verify plan-specific rules before scheduling PCI, especially in the ambulatory surgery center (ASC) setting.
## **C9600 applicable modifiers** Claims for PCI must include the appropriate modifiers to identify which vessel is undergoing a specific procedure. For C9600, the following modifiers are used: - **LD**: Left anterior descending coronary artery - **LC**: Left circumflex coronary artery - **RC**: Right coronary artery - **LM**: Left main artery - **RI**: Ramus intermedius artery These modifiers ensure accurate reporting of the target vessel and are required for proper adjudication under CMS and payer guidelines.
## **Other relevant codes** - **C9601**: Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) - **C9602**: Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch - **C9603**: Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) - **C9604**: Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy, and angioplasty, including distal protection when performed; single vessel - **C9605**: Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)

Frequently asked questions

C9600 is reported by facilities (hospitals and ASCs) for Medicare patients under OPPS. CPT 92928 is the professional services code used by physicians to bill for the same procedure.

Yes. Bill C9600 for the first major coronary artery or branch treated with a drug-eluting stent, and use C9601 for each additional coronary artery branch treated during the same session.

No. Under OPPS, C9600 is a device-intensive procedure, which means the cost of the drug-eluting stent is packaged into the procedure payment rather than paid separately.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments